|
|
|
Volumn 141, Issue 23, 1997, Pages 114-121
|
|
Advances and retreats in the pharmacotherapy of obesity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 DINITROPHENOL;
ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
AMPHETAMINE;
AMPHETAMINE DERIVATIVE;
ANOREXIGENIC AGENT;
BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;
CARNITINE;
CHOLECYSTOKININ RECEPTOR STIMULATING AGENT;
CHROMIUM;
DEXFENFLURAMINE;
EPHEDRINE;
FENFLURAMINE;
FLUOXETINE;
HERBACEOUS AGENT;
HYPERICUM EXTRACT;
INSULIN;
LEPTIN;
MELANOCORTIN;
NEUROPEPTIDE Y RECEPTOR ANTAGONIST;
PEROXISOME PROLIFERATOR;
PHENETHYLAMINE DERIVATIVE;
PHENTERMINE;
SEROTONIN AGONIST;
SIBUTRAMINE;
TETRAHYDROLIPSTATIN;
THYROID HORMONE;
TROGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
UNINDEXED DRUG;
CARDIOTOXICITY;
CLINICAL TRIAL;
DIABETES MELLITUS;
HUMAN;
NONHUMAN;
OBESITY;
PULMONARY HYPERTENSION;
REVIEW;
SIDE EFFECT;
WEIGHT REDUCTION;
|
|
EID: 0031464307
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
